Oil Price Slumps After Trump Calls Off Iran Attacks Strait of Hormuz Closure Spikes Volatility Trump Invests Heavily in Major Tech Stocks During First Quarter of 2026 Filings Reveal Fed Dissenters Explain No Votes Citing Disagreement Over RateCut Signal Charles River CRL Stock Down 445 Support Test at 14444 20260515 Chinese Investors Turn to Dividend Stocks as Market Options Narrow American Consumer Pessimism Persists as Inflation Geopolitical Risks and Trade Policies Weigh on Sentiment Eli Lilly Positioned as Potential SafeHaven Stock for LongTerm Investors in 2026 Ondas Holdings Pursues DefenseAI Strategy with Autonomous Systems Focus Accenture Invests in AIPowered Cybersecurity Platform XBOW Global Markets Rally on AI Boom Indian Equities Face Headwinds From Geopolitics and Oil Lear Corporation LEA Q1 2026 Earnings Strong EPS Beat Drives Stock Rally Amid Supply Chain Improvements ARAI Q1 2026 Earnings NarrowerthanExpected Loss Fails to Halt Share Decline VVV Q1 2026 Earnings EPS Surprise Beats Estimates Despite Stock Dip TEAM Q1 2026 Earnings Strong EPS Beat Drives Stock Rally GTX Q1 2026 Earnings EPS Surprise Lifts Results but Stock Slips COSO Q1 2026 Earnings EPS Misses Estimates amid Tightening Margins Melco Resorts Entertainment MLCO Edges Lower Amid Cautious Trading TransCode Therapeutics RNAZ Gains Over 2 as Biotech Stock Tests Key Resistance Levels Mayfair Gold Corp MINE Shares Retreat 45 as Gold Sector Faces Headwinds PDD Holdings Shares Drop Sharply Key Support Levels Under Pressure Finward Bancorp FNWD Edges Higher Amid Quiet Trading Tests Key Resistance Iran and US Explore 60Day Nuclear Deal Uranium Enrichment Sanctions Relief and Frozen Funds on Table PJT Partners Q1 2026 Earnings EPS Misses Estimates Stock Declines Fifth Third Bancorp Preferred Series K FITBO Holds Steady Near Support as Bank Sector Watches Rate Outlook Hubbell Q1 2026 Earnings Slight EPS Miss Fails to Dampen Investor Sentiment as Core Segments Hold Steady ADM Q1 2026 Earnings EPS Beat Drives Modest Stock Gain AMSC Q1 2026 Earnings EPS Surges Past Estimates Driving Stock Higher Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues BRBS Q1 2026 Earnings Positive EPS Amidst Limited Disclosure PRGS Q1 2026 Earnings Modest EPS Beat Amidst Solid Operational Performance GNLN Q2 2023 Earnings Significant Loss Per Share Misses Estimates Stock Declines